Articles producció científica> Medicina i Cirurgia

Does aging affect the immune status? A comparative analysis in 300 healthy volunteers from France, Austria and Spain

  • Identification data

    Identifier: imarina:5127472
    Authors:
    Vasson MPFarges MCGoncalves-Mendes NTalvas JRibalta JWinklhofer-Roob BRock ERossary A
    Abstract:
    Background As the European population is getting older, there is growing need in scientific data on how to achieve healthy and successful aging. A decline in immune function with age is unanimously supported by many epidemiological and clinical observations, with a decrease in T-cell mediated function encompassing a large part of this alteration. In the EU-funded VITAGE project, the effects of aging on biomarkers of immune status are being studied in three European countries. According to strict inclusion/exclusion criteria, a cohort of 300 healthy male non-smoking 20¿75 years old volunteers were enrolled in France (n = 99), Spain (n = 100) and Austria (n = 101). In each country, the volunteers were classified as a function of age (one age group per decade). Biomarkers of immune status were determined including delayed-type hypersensitivity tests, measurement of lymphocyte surface markers, and serum determinations of interleukin-2, complement fractions and immunoglobulins. Results There were moderate differences in the biomarkers of immune status of the VITAGE study volunteers among the three European centres. The percentage of Natural Killer (NK) cells was 156% and 142% higher in Spain as compared to France and Austria, respectively (p < 0.0001), and this increase was observed at any age group above 30 years. Comparison between age-groups showed that in Spain, but not in France or Austria, older individuals had significantly a lower B lymphocyte distribution and conversely, a higher NK cell distribution. Moreover, the CD4/CD8 ratio was positively correlated with age in Austrian subjects (p < 0.0001). Conclusion Our results provide evidence of an increased NK cell distribution in the elderly, especially in the Spanish population. NK cell status may predict morbidity and
  • Others:

    Author, as appears in the article.: Vasson MP; Farges MC; Goncalves-Mendes N; Talvas J; Ribalta J; Winklhofer-Roob B; Rock E; Rossary A
    Department: Medicina i Cirurgia
    URV's Author/s: Ribalta Vives, Josep
    Keywords: System Senieur protocol Nk cells Mediterranean diet Mediated-immunity Immune status Europe Elderly-people Delayed-type hypersensitivity Blood mononuclear-cells Biomarkers Aging Age
    Abstract: Background As the European population is getting older, there is growing need in scientific data on how to achieve healthy and successful aging. A decline in immune function with age is unanimously supported by many epidemiological and clinical observations, with a decrease in T-cell mediated function encompassing a large part of this alteration. In the EU-funded VITAGE project, the effects of aging on biomarkers of immune status are being studied in three European countries. According to strict inclusion/exclusion criteria, a cohort of 300 healthy male non-smoking 20¿75 years old volunteers were enrolled in France (n = 99), Spain (n = 100) and Austria (n = 101). In each country, the volunteers were classified as a function of age (one age group per decade). Biomarkers of immune status were determined including delayed-type hypersensitivity tests, measurement of lymphocyte surface markers, and serum determinations of interleukin-2, complement fractions and immunoglobulins. Results There were moderate differences in the biomarkers of immune status of the VITAGE study volunteers among the three European centres. The percentage of Natural Killer (NK) cells was 156% and 142% higher in Spain as compared to France and Austria, respectively (p < 0.0001), and this increase was observed at any age group above 30 years. Comparison between age-groups showed that in Spain, but not in France or Austria, older individuals had significantly a lower B lymphocyte distribution and conversely, a higher NK cell distribution. Moreover, the CD4/CD8 ratio was positively correlated with age in Austrian subjects (p < 0.0001). Conclusion Our results provide evidence of an increased NK cell distribution in the elderly, especially in the Spanish population. NK cell status may predict morbidity and mortality in the elderly, emphasizing the importance of innate as well as adaptive immunity in ensuring healthy longevity and cancer resistance, possibly in link with the Mediterranean diet.
    Thematic Areas: Saúde coletiva Odontología Nutrição Medicina ii Medicina i Interdisciplinar Immunology Geriatrics & gerontology Educação física Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Biotecnología Aging
    licence for use: https://creativecommons.org/licenses/by/3.0/es/
    Author's mail: josep.ribalta@urv.cat
    Author identifier: 0000-0002-8879-4719
    Record's date: 2023-02-18
    Papper version: info:eu-repo/semantics/publishedVersion
    Papper original source: Immunity & Ageing. 10 (1):
    APA: Vasson MP; Farges MC; Goncalves-Mendes N; Talvas J; Ribalta J; Winklhofer-Roob B; Rock E; Rossary A (2013). Does aging affect the immune status? A comparative analysis in 300 healthy volunteers from France, Austria and Spain. Immunity & Ageing, 10(1), -. DOI: 10.1186/1742-4933-10-38
    Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
    Entity: Universitat Rovira i Virgili
    Journal publication year: 2013
    Publication Type: Journal Publications
  • Keywords:

    Aging,Geriatrics & Gerontology,Immunology
    System
    Senieur protocol
    Nk cells
    Mediterranean diet
    Mediated-immunity
    Immune status
    Europe
    Elderly-people
    Delayed-type hypersensitivity
    Blood mononuclear-cells
    Biomarkers
    Aging
    Age
    Saúde coletiva
    Odontología
    Nutrição
    Medicina ii
    Medicina i
    Interdisciplinar
    Immunology
    Geriatrics & gerontology
    Educação física
    Ciências biológicas iii
    Ciências biológicas ii
    Ciências biológicas i
    Biotecnología
    Aging
  • Documents:

  • Cerca a google

    Search to google scholar